Oyster Point Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
27.50
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.53
|
-1.37
|
0.16
|
10.46%
|
|
2022-06-30
|
-1.66
|
-1.87
|
-0.21
|
-12.65%
|
|
2022-03-31
|
-1.74
|
-1.80
|
-0.06
|
-3.45%
|
|
2021-12-31
|
-1.39
|
-1.61
|
-0.22
|
-15.83%
|
|
2021-09-30
|
-1.16
|
-0.68
|
0.48
|
41.38%
|
|
2021-06-30
|
-0.85
|
-0.85
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.91
|
-0.73
|
0.18
|
19.78%
|
|
2020-12-31
|
-0.79
|
-0.86
|
-0.07
|
-8.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.04
|
|
2021-12-31
|
-3.87
|
|
2020-12-31
|
-2.92
|
|
2019-12-31
|
-9.51
|